ClinicalTrials.gov record
Comparison of Tiotropium in the HandiHaler Versus the Respimat in Chronic Obstructive Pulmonary Disease
ClinicalTrials.gov ID: NCT01126437
Public ClinicalTrials.gov record NCT01126437. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Active-controlled, Double-blind, Double-dummy, Parallel Group Design, Multi-center Trial to Compare the Efficacy and Safety of 2.5 µg and 5 µg Tiotropium Inhalation Solution Delivered by the Respimat Inhaler With Tiotropium Inhalation Capsules 18 µg Delivered by the HandiHaler (TIOSPIR)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Direct comparison studies of the tiotropium HandiHaler® 18 µg and Respimat® 5 µg formulations have been limited to 4-week crossover studies. Therefore, prospective data from a trial of adequate size and duration is required to establish that compared to tiotropium HandiHaler®, tiotropium Respimat® will have (a) similar effects on safety and (b) similar or superior effects on exacerbations.
Study identification
- NCT ID
- NCT01126437
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 17,183 participants
Conditions and interventions
Conditions
Interventions
- tiotropium 18 mcg Drug
- tiotropium 1.25 mcg (2 actuations/day) Drug
- tiotropium 2.5 mcg (2 actuations/day) Drug
Drug
Eligibility (public fields only)
- Age range
- 40 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 2010 (Type not available)
- Primary completion
- May 2013 (Actual)
- Completion
- May 2013 (Actual)
- Last update posted
- Jun 20, 2014
2010 – 2013
United States locations
- U.S. sites
- 303
- U.S. states
- 45
- U.S. cities
- 246
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| 205.452.01107 Boehringer Ingelheim Investigational Site | Athens | Alabama | — | — |
| 205.452.01023 Boehringer Ingelheim Investigational Site | Birmingham | Alabama | — | — |
| 205.452.01035 Boehringer Ingelheim Investigational Site | Birmingham | Alabama | — | — |
| 205.452.01052 Boehringer Ingelheim Investigational Site | Birmingham | Alabama | — | — |
| 205.452.01219 Boehringer Ingelheim Investigational Site | Birmingham | Alabama | — | — |
| 205.452.01227 Boehringer Ingelheim Investigational Site | Birmingham | Alabama | — | — |
| 205.452.01280 Boehringer Ingelheim Investigational Site | Birmingham | Alabama | — | — |
| 205.452.01198 Boehringer Ingelheim Investigational Site | Florence | Alabama | — | — |
| 205.452.01244 Boehringer Ingelheim Investigational Site | Mobile | Alabama | — | — |
| 205.452.01041 Boehringer Ingelheim Investigational Site | Montgomery | Alabama | — | — |
| 205.452.01070 Boehringer Ingelheim Investigational Site | Anchorage | Alaska | — | — |
| 205.452.01218 Boehringer Ingelheim Investigational Site | Chandler | Arizona | — | — |
| 205.452.01175 Boehringer Ingelheim Investigational Site | Mesa | Arizona | — | — |
| 205.452.01200 Boehringer Ingelheim Investigational Site | Mesa | Arizona | — | — |
| 205.452.01317 Boehringer Ingelheim Investigational Site | Mesa | Arizona | — | — |
| 205.452.01350 Boehringer Ingelheim Investigational Site | Pheonix | Arizona | — | — |
| 205.452.01254 Boehringer Ingelheim Investigational Site | Phoenix | Arizona | — | — |
| 205.452.01283 Boehringer Ingelheim Investigational Site | Phoenix | Arizona | — | — |
| 205.452.01315 Boehringer Ingelheim Investigational Site | Tempe | Arizona | — | — |
| 205.452.01158 Boehringer Ingelheim Investigational Site | Tucson | Arizona | — | — |
| 205.452.01161 Boehringer Ingelheim Investigational Site | Tucson | Arizona | — | — |
| 205.452.01302 Boehringer Ingelheim Investigational Site | Anaheim | California | — | — |
| 205.452.01038 Boehringer Ingelheim Investigational Site | Encinitas | California | — | — |
| 205.452.01313 Boehringer Ingelheim Investigational Site | Fountain Valley | California | — | — |
| 205.452.01375 Boehringer Ingelheim Investigational Site | Fountain Valley | California | — | — |
| 205.452.01074 Boehringer Ingelheim Investigational Site | Fullerton | California | — | — |
| 205.452.01345 Boehringer Ingelheim Investigational Site | Lancaster | California | — | — |
| 205.452.01171 Boehringer Ingelheim Investigational Site | Lincoln | California | — | — |
| 205.452.01339 Boehringer Ingelheim Investigational Site | Lomita | California | — | — |
| 205.452.01298 Boehringer Ingelheim Investigational Site | Los Angeles | California | — | — |
| 205.452.01356 Boehringer Ingelheim Investigational Site | Los Angeles | California | — | — |
| 205.452.01148 Boehringer Ingelheim Investigational Site | Orange | California | — | — |
| 205.452.01111 Boehringer Ingelheim Investigational Site | Palm Springs | California | — | — |
| 205.452.01147 Boehringer Ingelheim Investigational Site | Paramount | California | — | — |
| 205.452.01071 Boehringer Ingelheim Investigational Site | Poway | California | — | — |
| 205.452.01089 Boehringer Ingelheim Investigational Site | Rancho Cucamonga | California | — | — |
| 205.452.01097 Boehringer Ingelheim Investigational Site | Redlands | California | — | — |
| 205.452.01078 Boehringer Ingelheim Investigational Site | San Diego | California | — | — |
| 205.452.01176 Boehringer Ingelheim Investigational Site | San Diego | California | — | — |
| 205.452.01346 Boehringer Ingelheim Investigational Site | San Diego | California | — | — |
| 205.452.01306 Boehringer Ingelheim Investigational Site | San Jose | California | — | — |
| 205.452.01297 Boehringer Ingelheim Investigational Site | Santa Barbara | California | — | — |
| 205.452.01362 Boehringer Ingelheim Investigational Site | Tustin | California | — | — |
| 205.452.01225 Boehringer Ingelheim Investigational Site | Victorville | California | — | — |
| 205.452.01224 Boehringer Ingelheim Investigational Site | Walnut Creek | California | — | — |
| 205.452.01236 Boehringer Ingelheim Investigational Site | Wildomar | California | — | — |
| 205.452.01049 Boehringer Ingelheim Investigational Site | Colorado Springs | Colorado | — | — |
| 205.452.01245 Boehringer Ingelheim Investigational Site | Colorado Springs | Colorado | — | — |
| 205.452.01351 Boehringer Ingelheim Investigational Site | Denver | Colorado | — | — |
| 205.452.01018 Boehringer Ingelheim Investigational Site | Fort Collins | Colorado | — | — |
| 205.452.01005 Boehringer Ingelheim Investigational Site | Wheat Ridge | Colorado | — | — |
| 205.452.01024 Boehringer Ingelheim Investigational Site | Wheat Ridge | Colorado | — | — |
| 205.452.01199 Boehringer Ingelheim Investigational Site | Danbury | Connecticut | — | — |
| 205.452.01054 Boehringer Ingelheim Investigational Site | Hartford | Connecticut | — | — |
| 205.452.01072 Boehringer Ingelheim Investigational Site | Norwalk | Connecticut | — | — |
| 205.452.01040 Boehringer Ingelheim Investigational Site | Stamford | Connecticut | — | — |
| 205.452.01109 Boehringer Ingelheim Investigational Site | Waterbury | Connecticut | — | — |
| 205.452.01308 Boehringer Ingelheim Investigational Site | Newark | Delaware | — | — |
| 205.452.01011 Boehringer Ingelheim Investigational Site | Clearwater | Florida | — | — |
| 205.452.01209 Boehringer Ingelheim Investigational Site | Hialeah | Florida | — | — |
| 205.452.01360 Boehringer Ingelheim Investigational Site | Homestead | Florida | — | — |
| 205.452.01241 Boehringer Ingelheim Investigational Site | Jacksonville | Florida | — | — |
| 205.452.01337 Boehringer Ingelheim Investigational Site | Jacksonville | Florida | — | — |
| 205.452.01343 Boehringer Ingelheim Investigational Site | Jacksonville | Florida | — | — |
| 205.452.01184 Boehringer Ingelheim Investigational Site | Jupiter | Florida | — | — |
| 205.452.01138 Boehringer Ingelheim Investigational Site | Miami | Florida | — | — |
| 205.452.01246 Boehringer Ingelheim Investigational Site | Miami | Florida | — | — |
| 205.452.01321 Boehringer Ingelheim Investigational Site | Miami | Florida | — | — |
| 205.452.01290 Boehringer Ingelheim Investigational Site | New Port Richey | Florida | — | — |
| 205.452.01203 Boehringer Ingelheim Investigational Site | Ocala | Florida | — | — |
| 205.452.01174 Boehringer Ingelheim Investigational Site | Orlando | Florida | — | — |
| 205.452.01135 Boehringer Ingelheim Investigational Site | Ormond Beach | Florida | — | — |
| 205.452.01173 Boehringer Ingelheim Investigational Site | Oviedo | Florida | — | — |
| 205.452.01195 Boehringer Ingelheim Investigational Site | Panama City | Florida | — | — |
| 205.452.01197 Boehringer Ingelheim Investigational Site | Panama City | Florida | — | — |
| 205.452.01239 Boehringer Ingelheim Investigational Site | Pembroke Pines | Florida | — | — |
| 205.452.01247 Boehringer Ingelheim Investigational Site | Pembroke Pines | Florida | — | — |
| 205.452.01286 Boehringer Ingelheim Investigational Site | Pembroke Pines | Florida | — | — |
| 205.452.01240 Boehringer Ingelheim Investigational Site | Pensacola | Florida | — | — |
| 205.452.01260 Boehringer Ingelheim Investigational Site | Ponte Vedra | Florida | — | — |
| 205.452.01092 Boehringer Ingelheim Investigational Site | Rockledge | Florida | — | — |
| 205.452.01251 Boehringer Ingelheim Investigational Site | Sarasota | Florida | — | — |
| 205.452.01133 Boehringer Ingelheim Investigational Site | St. Petersburg | Florida | — | — |
| 205.452.01136 Boehringer Ingelheim Investigational Site | St. Petersburg | Florida | — | — |
| 205.452.01207 Boehringer Ingelheim Investigational Site | St. Petersburg | Florida | — | — |
| 205.452.01134 Boehringer Ingelheim Investigational Site | Tamarac | Florida | — | — |
| 205.452.01231 Boehringer Ingelheim Investigational Site | Tamarac | Florida | — | — |
| 205.452.01025 Boehringer Ingelheim Investigational Site | Tampa | Florida | — | — |
| 205.452.01250 Boehringer Ingelheim Investigational Site | Tampa | Florida | — | — |
| 205.452.01060 Boehringer Ingelheim Investigational Site | Winter Park | Florida | — | — |
| 205.452.01130 Boehringer Ingelheim Investigational Site | Atlanta | Georgia | — | — |
| 205.452.01047 Boehringer Ingelheim Investigational Site | Austell | Georgia | — | — |
| 205.452.01255 Boehringer Ingelheim Investigational Site | Columbus | Georgia | — | — |
| 205.452.01012 Boehringer Ingelheim Investigational Site | Conyers | Georgia | — | — |
| 205.452.01299 Boehringer Ingelheim Investigational Site | Gainesville | Georgia | — | — |
| 205.452.01288 Boehringer Ingelheim Investigational Site | Lawrenceville | Georgia | — | — |
| 205.452.01090 Boehringer Ingelheim Investigational Site | Snellville | Georgia | — | — |
| 205.452.01100 Boehringer Ingelheim Investigational Site | Honolulu | Hawaii | — | — |
| 205.452.01165 Boehringer Ingelheim Investigational Site | Boise | Idaho | — | — |
| 205.452.01059 Boehringer Ingelheim Investigational Site | Coeur d'Alene | Idaho | — | — |
| 205.452.01062 Boehringer Ingelheim Investigational Site | Eagle | Idaho | — | — |
| 205.452.01166 Boehringer Ingelheim Investigational Site | Hayden Lake | Idaho | — | — |
| 205.452.01275 Boehringer Ingelheim Investigational Site | Meridian | Idaho | — | — |
| 205.452.01330 Boehringer Ingelheim Investigational Site | Arlington Heights | Illinois | — | — |
| 205.452.01248 Boehringer Ingelheim Investigational Site | Belleville | Illinois | — | — |
| 205.452.01278 Boehringer Ingelheim Investigational Site | Chicago | Illinois | — | — |
| 205.452.01371 Boehringer Ingelheim Investigational Site | Downer Grove | Illinois | — | — |
| 205.452.01235 Boehringer Ingelheim Investigational Site | Lombard | Illinois | — | — |
| 205.452.01180 Boehringer Ingelheim Investigational Site | O'Fallon | Illinois | — | — |
| 205.452.01268 Boehringer Ingelheim Investigational Site | Oak Park | Illinois | — | — |
| 205.452.01359 Boehringer Ingelheim Investigational Site | Quincy | Illinois | — | — |
| 205.452.01347 Boehringer Ingelheim Investigational Site | Brownsburg | Indiana | — | — |
| 205.452.01153 Boehringer Ingelheim Investigational Site | Evansville | Indiana | — | — |
| 205.452.01301 Boehringer Ingelheim Investigational Site | Fishers | Indiana | — | — |
| 205.452.01141 Boehringer Ingelheim Investigational Site | Franklin | Indiana | — | — |
| 205.452.01137 Boehringer Ingelheim Investigational Site | Lafayette | Indiana | — | — |
| 205.452.01263 Boehringer Ingelheim Investigational Site | Muncie | Indiana | — | — |
| 205.452.01284 Boehringer Ingelheim Investigational Site | Council Bluffs | Iowa | — | — |
| 205.452.01021 Boehringer Ingelheim Investigational Site | Dubuque | Iowa | — | — |
| 205.452.01305 Boehringer Ingelheim Investigational Site | Lansing | Kansas | — | — |
| 205.452.01304 Boehringer Ingelheim Investigational Site | Olathe | Kansas | — | — |
| 205.452.01125 Boehringer Ingelheim Investigational Site | Overland Park | Kansas | — | — |
| 205.452.01068 Boehringer Ingelheim Investigational Site | Topeka | Kansas | — | — |
| 205.452.01063 Boehringer Ingelheim Investigational Site | Bowling Green | Kentucky | — | — |
| 205.452.01206 Boehringer Ingelheim Investigational Site | Fort Mitchell | Kentucky | — | — |
| 205.452.01289 Boehringer Ingelheim Investigational Site | Louisville | Kentucky | — | — |
| 205.452.01152 Boehringer Ingelheim Investigational Site | Paducah | Kentucky | — | — |
| 205.452.01015 Boehringer Ingelheim Investigational Site | Lafayette | Louisiana | — | — |
| 205.452.01091 Boehringer Ingelheim Investigational Site | Shreveport | Louisiana | — | — |
| 205.452.01329 Boehringer Ingelheim Investigational Site | Shreveport | Louisiana | — | — |
| 205.452.01364 Boehringer Ingelheim Investigational Site | Auburn | Maine | — | — |
| 205.452.01169 Boehringer Ingelheim Investigational Site | Bangor | Maine | — | — |
| 205.452.01022 Boehringer Ingelheim Investigational Site | Biddeford | Maine | — | — |
| 205.452.01053 Boehringer Ingelheim Investigational Site | Baltimore | Maryland | — | — |
| 205.452.01190 Boehringer Ingelheim Investigational Site | Elkridge | Maryland | — | — |
| 205.452.01336 Boehringer Ingelheim Investigational Site | Hollywood | Maryland | — | — |
| 205.452.01238 Boehringer Ingelheim Investigational Site | Towson | Maryland | — | — |
| 205.452.01243 Boehringer Ingelheim Investigational Site | Towson | Maryland | — | — |
| 205.452.01366 Boehringer Ingelheim Investigational Site | Fall River | Massachusetts | — | — |
| 205.452.01269 Boehringer Ingelheim Investigational Site | Haverhill | Massachusetts | — | — |
| 205.452.01208 Boehringer Ingelheim Investigational Site | New Bedford | Massachusetts | — | — |
| 205.452.01170 Boehringer Ingelheim Investigational Site | Worcester | Massachusetts | — | — |
| 205.452.01270 Boehringer Ingelheim Investigational Site | Ann Arbor | Michigan | — | — |
| 205.452.01349 Boehringer Ingelheim Investigational Site | Benzonia | Michigan | — | — |
| 205.452.01365 Boehringer Ingelheim Investigational Site | Chelsea | Michigan | — | — |
| 205.452.01149 Boehringer Ingelheim Investigational Site | Chesterfield | Michigan | — | — |
| 205.452.01146 Boehringer Ingelheim Investigational Site | Detroit | Michigan | — | — |
| 205.452.01139 Boehringer Ingelheim Investigational Site | Interlochen | Michigan | — | — |
| 205.452.01080 Boehringer Ingelheim Investigational Site | Kalamazoo | Michigan | — | — |
| 205.452.01310 Boehringer Ingelheim Investigational Site | Stevensville | Michigan | — | — |
| 205.452.01122 Boehringer Ingelheim Investigational Site | Traverse City | Michigan | — | — |
| 205.452.01081 Boehringer Ingelheim Investigational Site | Troy | Michigan | — | — |
| 205.452.01221 Boehringer Ingelheim Investigational Site | Troy | Michigan | — | — |
| 205.452.01205 Boehringer Ingelheim Investigational Site | Chaska | Minnesota | — | — |
| 205.452.01211 Boehringer Ingelheim Investigational Site | Edina | Minnesota | — | — |
| 205.452.01104 Boehringer Ingelheim Investigational Site | Fridley | Minnesota | — | — |
| 205.452.01113 Boehringer Ingelheim Investigational Site | Minneapolis | Minnesota | — | — |
| 205.452.01042 Boehringer Ingelheim Investigational Site | Rochester | Minnesota | — | — |
| 205.452.01019 Boehringer Ingelheim Investigational Site | Olive Branch | Mississippi | — | — |
| 205.452.01014 Boehringer Ingelheim Investigational Site | Chesterfield | Missouri | — | — |
| 205.452.01129 Boehringer Ingelheim Investigational Site | Saint Charles | Missouri | — | — |
| 205.452.01110 Boehringer Ingelheim Investigational Site | St Louis | Missouri | — | — |
| 205.452.01179 Boehringer Ingelheim Investigational Site | West Plains | Missouri | — | — |
| 205.452.01226 Boehringer Ingelheim Investigational Site | Billings | Montana | — | — |
| 205.452.01076 Boehringer Ingelheim Investigational Site | Butte | Montana | — | — |
| 205.452.01196 Boehringer Ingelheim Investigational Site | Missoula | Montana | — | — |
| 205.452.01150 Boehringer Ingelheim Investigational Site | Bellevue | Nebraska | — | — |
| 205.452.01187 Boehringer Ingelheim Investigational Site | Fremont | Nebraska | — | — |
| 205.452.01155 Boehringer Ingelheim Investigational Site | Omaha | Nebraska | — | — |
| 205.452.01073 Boehringer Ingelheim Investigational Site | Henderson | Nevada | — | — |
| 205.452.01031 Boehringer Ingelheim Investigational Site | Las Vegas | Nevada | — | — |
| 205.452.01261 Boehringer Ingelheim Investigational Site | Las Vegas | Nevada | — | — |
| 205.452.01026 Boehringer Ingelheim Investigational Site | Lebanon | New Hampshire | — | — |
| 205.452.01369 Boehringer Ingelheim Investigational Site | Newington | New Hampshire | — | — |
| 205.452.01296 Boehringer Ingelheim Investigational Site | Ocean City | New Jersey | — | — |
| 205.452.01046 Boehringer Ingelheim Investigational Site | Toms River | New Jersey | — | — |
| 205.452.01061 Boehringer Ingelheim Investigational Site | Albuquerque | New Mexico | — | — |
| 205.452.01167 Boehringer Ingelheim Investigational Site | Albuquerque | New Mexico | — | — |
| 205.452.01159 Boehringer Ingelheim Investigational Site | Bayside | New York | — | — |
| 205.452.01163 Boehringer Ingelheim Investigational Site | Bronxville | New York | — | — |
| 205.452.01194 Boehringer Ingelheim Investigational Site | Cooperstown | New York | — | — |
| 205.452.01131 Boehringer Ingelheim Investigational Site | Elmira | New York | — | — |
| 205.452.01142 Boehringer Ingelheim Investigational Site | Endwell | New York | — | — |
| 205.452.01192 Boehringer Ingelheim Investigational Site | Glens Falls | New York | — | — |
| 205.452.01279 Boehringer Ingelheim Investigational Site | Great Neck | New York | — | — |
| 205.452.01328 Boehringer Ingelheim Investigational Site | Honeoye Falls | New York | — | — |
| 205.452.01118 Boehringer Ingelheim Investigational Site | New Windsor | New York | — | — |
| 205.452.01127 Boehringer Ingelheim Investigational Site | New York | New York | — | — |
| 205.452.01058 Boehringer Ingelheim Investigational Site | Rochester | New York | — | — |
| 205.452.01085 Boehringer Ingelheim Investigational Site | Syracuse | New York | — | — |
| 205.452.01293 Boehringer Ingelheim Investigational Site | Syracuse | New York | — | — |
| 205.452.01151 Boehringer Ingelheim Investigational Site | Vestal | New York | — | — |
| 205.452.01188 Boehringer Ingelheim Investigational Site | Westfield | New York | — | — |
| 205.452.01271 Boehringer Ingelheim Investigational Site | Asheville | North Carolina | — | — |
| 205.452.01101 Boehringer Ingelheim Investigational Site | Burlington | North Carolina | — | — |
| 205.452.01264 Boehringer Ingelheim Investigational Site | Calabash | North Carolina | — | — |
| 205.452.01168 Boehringer Ingelheim Investigational Site | Charlotte | North Carolina | — | — |
| 205.452.01108 Boehringer Ingelheim Investigational Site | Elizabeth City | North Carolina | — | — |
| 205.452.01033 Boehringer Ingelheim Investigational Site | Greensboro | North Carolina | — | — |
| 205.452.01172 Boehringer Ingelheim Investigational Site | Greensboro | North Carolina | — | — |
| 205.452.01098 Boehringer Ingelheim Investigational Site | Hickory | North Carolina | — | — |
| 205.452.01115 Boehringer Ingelheim Investigational Site | Hickory | North Carolina | — | — |
| 205.452.01128 Boehringer Ingelheim Investigational Site | Raleigh | North Carolina | — | — |
| 205.452.01352 Boehringer Ingelheim Investigational Site | Rocky Mount | North Carolina | — | — |
| 205.452.01348 Boehringer Ingelheim Investigational Site | Salisbury | North Carolina | — | — |
| 205.452.01032 Boehringer Ingelheim Investigational Site | Statesville | North Carolina | — | — |
| 205.452.01276 Boehringer Ingelheim Investigational Site | Tabor City | North Carolina | — | — |
| 205.452.01157 Boehringer Ingelheim Investigational Site | Wilmington | North Carolina | — | — |
| 205.452.01363 Boehringer Ingelheim Investigational Site | Winston-Salem | North Carolina | — | — |
| 205.452.01193 Boehringer Ingelheim Investigational Site | Canal Fulton | Ohio | — | — |
| 205.452.01374 Boehringer Ingelheim Investigational Site | Centerville | Ohio | — | — |
| 205.452.01006 Boehringer Ingelheim Investigational Site | Cincinnati | Ohio | — | — |
| 205.452.01373 Boehringer Ingelheim Investigational Site | Cincinnati | Ohio | — | — |
| 205.452.01314 Boehringer Ingelheim Investigational Site | Cleveland | Ohio | — | — |
| 205.452.01210 Boehringer Ingelheim Investigational Site | Columbus | Ohio | — | — |
| 205.452.01232 Boehringer Ingelheim Investigational Site | Columbus | Ohio | — | — |
| 205.452.01309 Boehringer Ingelheim Investigational Site | Dayton | Ohio | — | — |
| 205.452.01140 Boehringer Ingelheim Investigational Site | Delaware | Ohio | — | — |
| 205.452.01084 Boehringer Ingelheim Investigational Site | Sylvania | Ohio | — | — |
| 205.452.01287 Boehringer Ingelheim Investigational Site | Toledo | Ohio | — | — |
| 205.452.01010 Boehringer Ingelheim Investigational Site | Oklahoma City | Oklahoma | — | — |
| 205.452.01094 Boehringer Ingelheim Investigational Site | Oklahoma City | Oklahoma | — | — |
| 205.452.01029 Boehringer Ingelheim Investigational Site | Tulsa | Oklahoma | — | — |
| 205.452.01043 Boehringer Ingelheim Investigational Site | Tulsa | Oklahoma | — | — |
| 205.452.01266 Boehringer Ingelheim Investigational Site | Ashland | Oregon | — | — |
| 205.452.01083 Boehringer Ingelheim Investigational Site | Bend | Oregon | — | — |
| 205.452.01189 Boehringer Ingelheim Investigational Site | Corvallis | Oregon | — | — |
| 205.452.01341 Boehringer Ingelheim Investigational Site | Springfield | Oregon | — | — |
| 205.452.01002 Boehringer Ingelheim Investigational Site | Altoona | Pennsylvania | — | — |
| 205.452.01354 Boehringer Ingelheim Investigational Site | Beaver | Pennsylvania | — | — |
| 205.452.01143 Boehringer Ingelheim Investigational Site | Carnegie | Pennsylvania | — | — |
| 205.452.01320 Boehringer Ingelheim Investigational Site | Downingtown | Pennsylvania | — | — |
| 205.452.01323 Boehringer Ingelheim Investigational Site | Erie | Pennsylvania | — | — |
| 205.452.01257 Boehringer Ingelheim Investigational Site | Jefferson Hills | Pennsylvania | — | — |
| 205.452.01332 Boehringer Ingelheim Investigational Site | Langhorne | Pennsylvania | — | — |
| 205.452.01075 Boehringer Ingelheim Investigational Site | Norristown | Pennsylvania | — | — |
| 205.452.01087 Boehringer Ingelheim Investigational Site | Philadelphia | Pennsylvania | — | — |
| 205.452.01144 Boehringer Ingelheim Investigational Site | Philadelphia | Pennsylvania | — | — |
| 205.452.01003 Boehringer Ingelheim Investigational Site | Pittsburgh | Pennsylvania | — | — |
| 205.452.01361 Boehringer Ingelheim Investigational Site | Pittsburgh | Pennsylvania | — | — |
| 205.452.01036 Boehringer Ingelheim Investigational Site | Pleasant Hills | Pennsylvania | — | — |
| 205.452.01106 Boehringer Ingelheim Investigational Site | Uniontown | Pennsylvania | — | — |
| 205.452.01156 Boehringer Ingelheim Investigational Site | Uniontown | Pennsylvania | — | — |
| 205.452.01204 Boehringer Ingelheim Investigational Site | Warminster | Pennsylvania | — | — |
| 205.452.01338 Boehringer Ingelheim Investigational Site | Wyomissing | Pennsylvania | — | — |
| 205.452.01267 Boehringer Ingelheim Investigational Site | Cranston | Rhode Island | — | — |
| 205.452.01214 Boehringer Ingelheim Investigational Site | Johnston | Rhode Island | — | — |
| 205.452.01340 Boehringer Ingelheim Investigational Site | Anderson | South Carolina | — | — |
| 205.452.01066 Boehringer Ingelheim Investigational Site | Charleston | South Carolina | — | — |
| 205.452.01217 Boehringer Ingelheim Investigational Site | Columbia | South Carolina | — | — |
| 205.452.01303 Boehringer Ingelheim Investigational Site | Easley | South Carolina | — | — |
| 205.452.01259 Boehringer Ingelheim Investigational Site | Florence | South Carolina | — | — |
| 205.452.01013 Boehringer Ingelheim Investigational Site | Gaffney | South Carolina | — | — |
| 205.452.01077 Boehringer Ingelheim Investigational Site | Greenville | South Carolina | — | — |
| 205.452.01093 Boehringer Ingelheim Investigational Site | Greer | South Carolina | — | — |
| 205.452.01295 Boehringer Ingelheim Investigational Site | Hodges | South Carolina | — | — |
| 205.452.01335 Boehringer Ingelheim Investigational Site | Myrtle Beach | South Carolina | — | — |
| 205.452.01056 Boehringer Ingelheim Investigational Site | Rock Hill | South Carolina | — | — |
| 205.452.01294 Boehringer Ingelheim Investigational Site | Spartanburg | South Carolina | — | — |
| 205.452.01004 Boehringer Ingelheim Investigational Site | Rapid City | South Dakota | — | — |
| 205.452.01126 Boehringer Ingelheim Investigational Site | Brentwood | Tennessee | — | — |
| 205.452.01220 Boehringer Ingelheim Investigational Site | Chattanooga | Tennessee | — | — |
| 205.452.01324 Boehringer Ingelheim Investigational Site | Chattanooga | Tennessee | — | — |
| 205.452.01342 Boehringer Ingelheim Investigational Site | Kingsport | Tennessee | — | — |
| 205.452.01096 Boehringer Ingelheim Investigational Site | Arlington | Texas | — | — |
| 205.452.01050 Boehringer Ingelheim Investigational Site | Corsicana | Texas | — | — |
| 205.452.01233 Boehringer Ingelheim Investigational Site | Dallas | Texas | — | — |
| 205.452.01334 Boehringer Ingelheim Investigational Site | Dallas | Texas | — | — |
| 205.452.01057 Boehringer Ingelheim Investigational Site | Fort Worth | Texas | — | — |
| 205.452.01181 Boehringer Ingelheim Investigational Site | Fort Worth | Texas | — | — |
| 205.452.01272 Boehringer Ingelheim Investigational Site | Fort Worth | Texas | — | — |
| 205.452.01082 Boehringer Ingelheim Investigational Site | Houston | Texas | — | — |
| 205.452.01105 Boehringer Ingelheim Investigational Site | Houston | Texas | — | — |
| 205.452.01178 Boehringer Ingelheim Investigational Site | Houston | Texas | — | — |
| 205.452.01212 Boehringer Ingelheim Investigational Site | Houston | Texas | — | — |
| 205.452.01274 Boehringer Ingelheim Investigational Site | Longview | Texas | — | — |
| 205.452.01116 Boehringer Ingelheim Investigational Site | McKinney | Texas | — | — |
| 205.452.01262 Boehringer Ingelheim Investigational Site | Richardson | Texas | — | — |
| 205.452.01055 Boehringer Ingelheim Investigational Site | San Antonio | Texas | — | — |
| 205.452.01182 Boehringer Ingelheim Investigational Site | San Antonio | Texas | — | — |
| 205.452.01186 Boehringer Ingelheim Investigational Site | San Antonio | Texas | — | — |
| 205.452.01353 Boehringer Ingelheim Investigational Site | San Antonio | Texas | — | — |
| 205.452.01215 Boehringer Ingelheim Investigational Site | Sugar Land | Texas | — | — |
| 205.452.01223 Boehringer Ingelheim Investigational Site | Midvale | Utah | — | — |
| 205.452.01001 Boehringer Ingelheim Investigational Site | Salt Lake City | Utah | — | — |
| 205.452.01079 Boehringer Ingelheim Investigational Site | Abingdon | Virginia | — | — |
| 205.452.01234 Boehringer Ingelheim Investigational Site | Alexandria | Virginia | — | — |
| 205.452.01065 Boehringer Ingelheim Investigational Site | Danville | Virginia | — | — |
| 205.452.01285 Boehringer Ingelheim Investigational Site | Danville | Virginia | — | — |
| 205.452.01045 Boehringer Ingelheim Investigational Site | Ettrick | Virginia | — | — |
| 205.452.01030 Boehringer Ingelheim Investigational Site | Lynchburg | Virginia | — | — |
| 205.452.01016 Boehringer Ingelheim Investigational Site | Richmond | Virginia | — | — |
| 205.452.01039 Boehringer Ingelheim Investigational Site | Richmond | Virginia | — | — |
| 205.452.01044 Boehringer Ingelheim Investigational Site | Richmond | Virginia | — | — |
| 205.452.01300 Boehringer Ingelheim Investigational Site | Richmond | Virginia | — | — |
| 205.452.01099 Boehringer Ingelheim Investigational Site | Selah | Washington | — | — |
| 205.452.01008 Boehringer Ingelheim Investigational Site | Spokane | Washington | — | — |
| 205.452.01069 Boehringer Ingelheim Investigational Site | Spokane | Washington | — | — |
| 205.452.01145 Boehringer Ingelheim Investigational Site | Spokane | Washington | — | — |
| 205.452.01185 Boehringer Ingelheim Investigational Site | Tacoma | Washington | — | — |
| 205.452.01007 Boehringer Ingelheim Investigational Site | Wenatchee | Washington | — | — |
| 205.452.01201 Boehringer Ingelheim Investigational Site | Oregon | Wisconsin | — | — |
| 205.452.01344 Boehringer Ingelheim Investigational Site | West Allis | Wisconsin | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 888 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01126437, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 20, 2014 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01126437 live on ClinicalTrials.gov.